1. Home
  2. WST vs FFIV Comparison

WST vs FFIV Comparison

Compare WST & FFIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • FFIV
  • Stock Information
  • Founded
  • WST 1923
  • FFIV 1996
  • Country
  • WST United States
  • FFIV United States
  • Employees
  • WST N/A
  • FFIV N/A
  • Industry
  • WST Medical/Dental Instruments
  • FFIV Computer Communications Equipment
  • Sector
  • WST Health Care
  • FFIV Telecommunications
  • Exchange
  • WST Nasdaq
  • FFIV Nasdaq
  • Market Cap
  • WST 20.1B
  • FFIV 16.7B
  • IPO Year
  • WST N/A
  • FFIV 1999
  • Fundamental
  • Price
  • WST $259.65
  • FFIV $225.20
  • Analyst Decision
  • WST Strong Buy
  • FFIV Hold
  • Analyst Count
  • WST 9
  • FFIV 11
  • Target Price
  • WST $354.50
  • FFIV $297.22
  • AVG Volume (30 Days)
  • WST 733.1K
  • FFIV 1.1M
  • Earning Date
  • WST 10-23-2025
  • FFIV 10-27-2025
  • Dividend Yield
  • WST 0.34%
  • FFIV N/A
  • EPS Growth
  • WST 0.17
  • FFIV 23.56
  • EPS
  • WST 6.75
  • FFIV 11.80
  • Revenue
  • WST $3,017,900,000.00
  • FFIV $3,088,072,000.00
  • Revenue This Year
  • WST $6.97
  • FFIV $4.08
  • Revenue Next Year
  • WST $6.11
  • FFIV $3.95
  • P/E Ratio
  • WST $38.36
  • FFIV $19.03
  • Revenue Growth
  • WST 4.92
  • FFIV 9.66
  • 52 Week Low
  • WST $187.43
  • FFIV $223.91
  • 52 Week High
  • WST $348.90
  • FFIV $346.00
  • Technical
  • Relative Strength Index (RSI)
  • WST 39.02
  • FFIV 18.60
  • Support Level
  • WST $258.93
  • FFIV $237.54
  • Resistance Level
  • WST $266.26
  • FFIV $243.77
  • Average True Range (ATR)
  • WST 8.72
  • FFIV 5.77
  • MACD
  • WST -3.16
  • FFIV -0.40
  • Stochastic Oscillator
  • WST 9.50
  • FFIV 0.36

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About FFIV F5 Inc.

F5 is a market leader in the application delivery controller market. The company sells products for security, application performance, and automation. Its three customer verticals are enterprises, service providers, and government entities. Revenue is evenly split between its services business and products business with revenue trending toward products due to software adoption. The Seattle-based firm was incorporated in 1996, and went public in 1999.

Share on Social Networks: